Dr. Durkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Campus Box 8051
4523 Clayton Ave
Saint Louis, MO 63110Phone+1 314-362-9098Fax+1 314-362-9851
Summary
- Dr. Michael Durkin is an infectious disease specialist in Saint Louis, MO and is affiliated with Barnes-Jewish Hospital and Washington University School of Medicine. He received his medical degree from Medical College of Wisconsin and has been in practice 9 years. He specializes in healthcare associated infections and is experienced in general infectious disease, public health, epidemiology, infection control, and antibiotic stewardship.
Education & Training
University of North CarolinaMPH, Epidemiology, 2013 - 2015
Duke University HospitalFellowship, Infectious Disease, 2012 - 2015
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2008 - 2011
Medical College of WisconsinClass of 2008
Certifications & Licensure
MO State Medical License 2011 - 2025
NC State Medical License 2012 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Fellow Society for Healthcare Epidemiology of America, 2022
- Fellow Infectious Diseases Society of America, 2021
Clinical Trials
- CTTI Risk Factors for HABP/VABP Study Start of enrollment: 2016 Feb 01
- Nutraceutical Efficacy for rUTI Start of enrollment: 2018 Mar 22
- Stigma and a Shared Decision Aid Start of enrollment: 2022 Apr 07
- Join now to see all
Publications & Presentations
PubMed
- 127 citationsAddiction Medicine Consultations Reduce Readmission Rates for Patients With Serious Infections From Opioid Use Disorder.Laura R. Marks, Satish Munigala, David K. Warren, Stephen Y. Liang, Evan S. Schwarz
Clinical Infectious Diseases. 2019-05-17 - 2 citationsAttitudes toward using clinical decision support in community pharmacies to promote antibiotic stewardshipSena Sayood, Margaret Botros, Katie J. Suda, Randi E. Foraker, Michael J. Durkin
Journal of the American Pharmacists Association. 2021-09-01 - 24 citationsMedications for Opioid use Disorder Associated With Less Against Medical Advice Discharge Among Persons Who Inject Drugs Hospitalized With an Invasive Infection.Nathanial S Nolan, Laura R. Marks, Stephen Y. Liang, Michael J. Durkin
Journal of Addiction Medicine. 2021-04-01
Journal Articles
- Addiction Medicine Consultations Reduce Readmission Rates for Patients with Serious Infections from Opioid Use DisorderDavid K Warren, Michael J Durkin, Evan S Schwarz, Clinical Infectious Diseases
Books/Book Chapters
Press Mentions
IDSA Honors 199 Distinguished Clinicians, Scientists with FIDSA DesignationNovember 16th, 2021
Halting Opioid Abuse Aim of Several Grants from NIH, CDCDecember 3rd, 2019
Grant Support
- Developmental Center for AIDS Research Grant - Scientific Working GroupNIH(NIAID) - Co-I on D-CFAR and Co-PI of Scientific Working Group2024–2029
- Informatics Approaches to Understand and Reduce Inappropriate Antibiotic Prescribing by DentistsNIH(NIDCR)2023–2028
- Comparative Risk of Oral Complications Associated with Medications for Opioid Use Disorder: A Mixed-Methods ApproachNIH (NIDCR)2023–2028
- Identifying Optimal Antibiotic Regimens to Treat Urinary Tract Infections During PregnancyNIH(NICHD)2022–2027
- Washington University & BJC Epicenter to Prevent Healthcare Associated Infections & Antibiotic ResistanceCDC2021–2026
- Using Implementation Science and Informatics to Develop and Pilot Test Antibiotic Stewardship Clinical Decision SupportNIH(NIDCR)2021–2026
- Impact of removing low yield penicillin allergy alerts on surgical site infection ratesAHRQ2024–2025
- Dental Safety of Transmucosal Buprenorphine Among Individuals Receiving OpioidsNIH(NIDA)2023–2025
- Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter NetworkCDC(NCEZID)2020–2025
- Stakeholders' Perceptions of Consensus Guidelines about Antibiotics for Asymptomatic BacteriuriaWashington University Institute for Clinical and Translational Sciences2023–2024
- Moving Upstream – Expanding Harm Reduction Training and Low‐Barrier Care for Unstably Housed People Who Inject DrugsWashington University Institute for Public Health2023–2024
- Piloting a Shared Decision-Making Aid for Reducing Stigma in Drug Use and HIV Harm Reduction in a Rural SettingNIDA2021–2023
- Evaluation of Aerosol Composition in Dental SettingsNIH(NIDCR)2021–2022
- Dissemination and Implementation of a HCV telehealth program for persons who inject drugsWashington University ICTS2021–2022
- Determining the acceptability and feasibility of mobile-health approaches to gather clinical information from patients at home following hospital dischargeNCATS2020–2022
- Loan Repayment ProgramNIH (NIAID and NIDCR)2017–2022
- Research on the cost of inappropriate antibiotic prescribing in outpatient healthcare settingsPew Charitable Trusts2020–2021
- Assessment of Personal Protective Equipment for Dental Healthcare ProfessionalsNIH (NIDCR)2020–2021
- Evaluation of Aerosol Generating Procedures in Dental SettingsNIH (NIDCR)2020–2021
- Increasing use of MAT to address opioid use among patients with bacterial and fungal infections related to injection drug use - RuralCDC SHEPheRD2019–2021
- Increasing use of MAT to address opioid use among patients with bacterial and fungal infections related to injection drug use - UrbanCDC SHEPheRD Contract2019–2021
- Washington University & BJC Epicenter for Prevention of Healthcare Associated InfectionsCDC2016–2021
- Antimicrobial Stewardship ActivitiesCDC2018–2020
- KL2Washington University ICTS/NIH (NCATS)2016–2019
Professional Memberships
- Member
- Society for Healthcare Epidemiology of AmericaMember
- International Association for Dental ResearchMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
